Erudio Healtherudio.com
Clinical trial · no report yet · Phase not applicable
NCT02756793
Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)
- NCT02756793 ↗
- Active, not recruiting
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Deep
We haven't built an HCP commentary report on NCT02756793 (Metastatic Cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT02756793 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 26 | |
| Podcasts | 8 | |
| YouTube | 4 |
The trial
ClinicalTrials.gov- Official title
- Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial): A Randomized Phase II Trial
- Phase
- Phase not applicable
- Status
- Active, not recruiting
- Conditions
- Metastatic Cancer
- Interventions
- Stereotactic Ablative Radiotherapy (SABR); Standard of Care Treatment
- Arms
- Standard of Care Treatment · Active comparator
- Stereotactic Ablative Radiotherapy (SABR) · Experimental
- Enrollment
- 90
- Primary outcomes
- Progression-Free Survival
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Start
- Oct 2016
- Primary completion
- Jul 31, 2022
- Results posted
- No
- Registry record
- NCT02756793 · updated Dec 31, 2025
Publications
linked from the registry- Schellenberg D, Gabos Z, Duimering A, Debenham B, Fairchild A, Huang F, Rowe LS, Severin D, Giuliani ME, Bezjak A, Lok BH, Raman S, Chung P, Zhao Y, Ho CK, Lock M, Louie AV, Lefresne S, Carolan H, Liu M, Yau V, Ye A, Olson RA, Mou B, Mohamed IG, Petrik DW, Dosani M, Pai H, Valev B, Gaede S, Warner A, Palma DA. Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial. Int J Radiat Oncol Biol Phys. 2025 Jan 1;121(1):28-38. doi: 10.1016/j.ijrobp.2024.08.031. Epub 2024 Aug 19. PubMed 39168356
- Lee J, Koom WS, Byun HK, Yang G, Kim MS, Park EJ, Ahn JB, Beom SH, Kim HS, Shin SJ, Kim K, Chang JS. Metastasis-Directed Radiotherapy for Oligoprogressive or Oligopersistent Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2022 Jun;21(2):e78-e86. doi: 10.1016/j.clcc.2021.10.009. Epub 2021 Nov 18. PubMed 34903471